Muscle & Brawn 2.0 is live! New Tools, Voice Reader, Compound Index, Features and more on the way. Want to explore what’s new → Click Here
Independent & reader-supported — every article medically reviewed

Peptides / Incretin and metabolic peptides

127 In the index

Orforglipron alternative ORFO-2

A term used in gray-market listings for products claiming to copy orforglipron's effects outside of real pharmaceutical channels. Since orforglipron itself isn't approved yet, any such 'alternative' product has no independent verification of what's actually in it or whether it works.

Also known as Oral incretin

Effects Lose fat
Routes Oral
Legal status Unapproved / investigational
WADA Not listed

Molecular Structure of C48H48F2N10O5

Drag to rotate · scroll to zoom

  • Carbon
  • Hydrogen
  • Fluorine
  • Nitrogen
  • Oxygen

PubChem has no 3D conformer for this molecule, so this is the flat structure.

Chemistry

Formula
C48H48F2N10O5
Molar mass
883.0
CAS
2212020-52-3
PubChem CID
137319706

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose Not established; refers to compounded/analog versions, not the approved product
Reported range Varies by compounding source
Route Oral
Frequency Varies
Duration Not established

Distinguish from the approved Eli Lilly product: compounded or gray-market 'alternative' versions are not FDA-approved, are not verified for purity/potency, and carry additional, unstudied risk beyond the approved drug itself.

Where this comes from Compounding-pharmacy/gray-market vendor literature; no controlled trials of these specific products

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.